In contrast to the HLA-B27 tg model, therapeutic treatment with anti-IL-23p19 in curdlan-induced SpA in SKG mice induced a significant albeit small reduction in spondylitis and arthritis scores (21). The gene discussed is IL23A; the disease is spondylitis.